LungBlog

More than a third of the United Kingdom’s 10 million smokers say they plan to quit the habit Sunday when new anti-smoking laws take effect.Lloyds TSB Savings Bank said its survey suggests the 40 percent of British smokers going through 20 cigarettes a day will save about $4,000 annually.

With England about to go non-smoking on 1st July, AQA (Any Question Answered), the text question and answer service, is on hand 24/7 to help smokers put out their cigarettes.

ANOTHER health risk associated with smoking is lung cancer, a disease which kills more than 20,000 people in the UK every year.

Lung cancer is a difficult cancer to treat and long term survival rates are poor.

There isn’t a word to sum up thank you a million times, but Ken Janzen said there should be one because sometimes a plain old thank you isn’t enough.

The St. Catharines musician with terminal lung cancer was “stunned” by the support he got from the community Sunday.

Pfizer’s late-stage pipeline has suffered another blow with the news that the firm has terminated trials of an experimental lung cancer treatment.

 Hank Medress, whose vocals with the doo wop group the Tokens helped propel their irrepressible single “The Lion Sleeps Tonight” to the top of the charts and who produced hits with other groups, has died of lung cancer. He was 68.

No. 7: Quit smoking, today

CANCER sufferers in West Cumbria are being denied drugs which may prolong their lives.

Lung cancer drug Tarceva is free to patients in Scotland but Cumbria Primary Care Trust will not pay for it because it has not been approved by the national health watchdog.

Attorney Bryan Blevins of Provost Umphrey has filed a suit on behalf of refinery worker Mark McCall against A.O. Smith and 61 other corporations for distributing asbestos containing products.The plaintiff smoked cigarettes for 36 years and has lung cancer.

Pfizer Inc. announced that it has discontinued its development program in lung cancer for PF-3512676, an investigational compound, in combination with cytotoxic chemotherapy. This includes two Phase 3 clinical trials and two Phase 2 clinical trials.